Russian Patent Office Provides Notification of Intention to Grant Hythiam, Inc. Patent for Treatment of Cocaine Dependence
Published: Nov 05, 2007
LOS ANGELES--(BUSINESS WIRE)--Hythiam, Inc. (NASDAQ:HYTM) today announced that the Russian Patent Office has informed Hythiam of their decision to grant Hythiam’s patent for the use of a composition of matter for the treatment of cocaine dependency. The patent will serve to enhance protection of the intellectual property underlying the company’s PROMETA® Treatment Program for cocaine dependence and follows the granting of cocaine patents in other major markets over the past 12 months, including the U.S., Europe, Japan, and Korea. The Russian Patent Office granted Hythiam a similar patent for the treatment of alcohol dependency in 2006.